Overview of CART-Related Neurotoxicity
Chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a groundbreaking treatment approach for various hematological cancers, including B-cell lymphomas, acute lymphoblastic leukemia, and multiple myeloma. By genetically engineering patients' T cells to identify and destroy malignant cells, this innovative immunotherapy has demonstrated...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek